A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas
- PMID: 17881972
- DOI: 10.1227/01.NEU.0000290906.53685.79
A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas
Abstract
Objective: The aims of this study are to review the histology of the clinically nonfunctioning pituitary adenomas (CNFPAs) we have observed and to determine whether or not the frequency of cavernous sinus invasion is different among each type of morphology.
Methods: In addition, several proliferative markers, including Ki67, p53, E-cadherin, matrix metallo-proteinase 9 and pituitary tumor derived fibroblast growth factor receptor 4 (ptd-FGFR4), were also investigated in invasive and non-invasive tumors.
Results: Our consequent 213 CNFPAs were diagnosed as follows: 64% were silent gonadotroph adenomas, 18% were null cell adenomas, 12% were silent corticotroph adenomas, 4% were silent Subtype 3 adenomas, and 1% were other types of adenomas. Female patients or younger patients showed a significant preponderance in silent corticotroph adenomas and in silent Subtype 3 adenomas, respectively. Cavernous sinus invasion occurs most frequently in silent corticotroph adenomas (85%) followed by Subtype 3 adenomas (67%), null cell adenomas (38%), and silent gonadotroph adenomas (11%). There were no significant differences in the Ki67, p53, E-cadherin, matrix metallo-proteinase 9, and ptd-FGFR4 expression between tumors with and without cavernous sinus invasion.
Conclusion: From a clinical standpoint, it is quite important to differentiate morphological type in CNFPAs to aid the clinician in assessing the clinical behavior and prognosis of the tumor. Therefore, we suggest that all CNFPAs be examined not only by conventional light microscopy but also by immunohistochemistry, preferably by electron microscopy, to achieve a correct morphological diagnosis.
Similar articles
-
p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions.Neurosurgery. 1996 Apr;38(4):765-70; discussion 770-1. Neurosurgery. 1996. PMID: 8692397
-
Clinical features of silent corticotroph adenomas.Acta Neurochir (Wien). 2012 Aug;154(8):1493-8. doi: 10.1007/s00701-012-1378-1. Epub 2012 May 24. Acta Neurochir (Wien). 2012. PMID: 22619024
-
A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.Neurol India. 2010 May-Jun;58(3):418-23. doi: 10.4103/0028-3886.66336. Neurol India. 2010. PMID: 20644271
-
Clinically non-functioning human pituitary adenomas.Can J Neurol Sci. 1992 May;19(2):228-35. Can J Neurol Sci. 1992. PMID: 1623451 Review.
-
Clinical Implications of Accurate Subtyping of Pituitary Adenomas: Perspectives from the Treating Physician.Turk Patoloji Derg. 2015;31 Suppl 1:4-17. doi: 10.5146/tjpath.2015.01311. Turk Patoloji Derg. 2015. PMID: 26177314 Review.
Cited by
-
The role of mediators of cell invasiveness, motility, and migration in the pathogenesis of silent corticotroph adenomas.Endocr Pathol. 2013 Dec;24(4):191-8. doi: 10.1007/s12022-013-9270-y. Endocr Pathol. 2013. PMID: 24091601
-
Follicle-Stimulating Hormone-Secreting Pituitary Adenoma Inducing Spontaneous Ovarian Hyperstimulation Syndrome, Treatment Using In Vitro Fertilization and Embryo Transfer: A Case Report.Front Endocrinol (Lausanne). 2021 Jun 24;12:621456. doi: 10.3389/fendo.2021.621456. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34248835 Free PMC article.
-
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors.Endocrinol Metab (Seoul). 2023 Dec;38(6):631-654. doi: 10.3803/EnM.2023.1838. Epub 2023 Nov 15. Endocrinol Metab (Seoul). 2023. PMID: 37964483 Free PMC article. Review.
-
Ovarian Hyperstimulation Syndrome Caused by Functional Gonadotroph Pituitary Adenoma.JCEM Case Rep. 2023 Jul 14;1(4):luad087. doi: 10.1210/jcemcr/luad087. eCollection 2023 Jul. JCEM Case Rep. 2023. PMID: 37908987 Free PMC article.
-
Clinical profile of silent growth hormone pituitary adenomas; higher recurrence rate compared to silent gonadotroph pituitary tumors, a large single center experience.Endocrine. 2017 Dec;58(3):528-534. doi: 10.1007/s12020-017-1447-6. Epub 2017 Oct 17. Endocrine. 2017. PMID: 29043561
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous